4740.0 - Future Aboriginal and Torres Strait Islander Health Surveys - Have Your Say , 2020  
Latest ISSUE Released at 11:30 AM (CANBERRA TIME) 10/03/2020   
   Page tools: Print Print Page Print all pages in this productPrint All RSS Feed RSS Bookmark and Share Search this Product

BIOMEDICAL TESTS IN THE 2012-13 NATSIHS


Cardiovascular disease

Biomarker
Rationale
Total cholesterol
To estimate prevalence of cardiovascular disease risk factors
Fasting triglycerides
Fasting LDL and HDL cholesterol
Apolipoprotein B

Diabetes

Biomarker
Rationale
Fasting plasma glucoseTo estimate prevalence of diabetes and impaired fasting glucose
Glycated haemoglobin HbA1cTo monitor diabetes control

Chronic kidney disease

Biomarker
Rationale
Estimated Glomerular Filtration Rate (eGFR)To estimate prevalence and severity of kidney damage
Urinary albumin creatinine ratio (ACR)To estimate prevalence of albuminurea, an early indicator of kidney damage

Liver function

Biomarker
Rationale
Liver function tests (GGT and ALT)To provide an indication of prevalence of liver damage

Risk Factors

Biomarker
Rationale
Serum cotinineTo estimate prevalence of active and passive smoking

Nutrition status

Biomarker
Rationale
Erythrocyte folateTo monitor the effectiveness of folate food fortification programs and estimate prevalence of folate deficiency
Serum folate
Serum B12To estimate prevalence of vitamin B12 deficiency
Urinary sodium and potassium concentrationTo measure population trends in sodium and potassium intakes
Serum 25(OH)DTo estimate prevalence of vitamin D deficiency
Urinary iodineTo monitor the effectiveness of iodine food fortification programs and estimate prevalence of iodine deficiency
Serum ferritinTo estimate prevalence and severity of iron deficiency
Serum transferrin receptor
Haemoglobin
Inflammation marker (CRP)To assist with iron interpretations